Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T18:27:33.285Z.
Calculation as of: 2026-10-06T18:27:33.285Z.
Quote observation: 2026-10-06T18:25:08.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 2ce25f957fe83095360266a8eba44a0c9f304ca71e6017df3a9cc6b1c586d311
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
MapLight Therapeutics, Inc.
Market Cap
$420.28M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$420.34M
Free Cash Flow Yield
N/A
TTM Avg
4.42%
3Y Avg
4.42%
5Y Avg
4.42%
Market Cap
$425.13M
Free Cash Flow Yield
N/A
TTM Avg
0.98%
3Y Avg
0.98%
5Y Avg
0.98%
Market Cap
$414.18M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$412.28M
Free Cash Flow Yield
N/A
TTM Avg
0.50%
3Y Avg
0.50%
5Y Avg
0.50%
Market Cap
$414.54M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$429.88M
Free Cash Flow Yield
N/A
TTM Avg
3.29%
3Y Avg
4.78%
5Y Avg
5.98%
Market Cap
$410.18M
Free Cash Flow Yield
N/A
TTM Avg
0.27%
3Y Avg
3.53%
5Y Avg
4.14%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MapLight Therapeutics, Inc. (MPLT) | $420.28M | N/A | N/A | N/A | N/A |
| Prothena Corporation plc (PRTA)vs › | $420.34M | N/A | 4.42% | 4.42% | 4.42% |
| ARS Pharmaceuticals, Inc. (SPRY)vs › | $425.13M | N/A | 0.98% | 0.98% | 0.98% |
| Tilray Brands, Inc. (TLRY)vs › | $425.52M | N/A | N/A | N/A | N/A |
| Senseonics Holdings, Inc. (SENS)vs › | $414.18M | N/A | N/A | N/A | N/A |
| Strata Critical Medical, Inc. (SRTA)vs › | $412.28M | N/A | 0.50% | 0.50% | 0.50% |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $414.54M | N/A | N/A | N/A | N/A |
| NeoGenomics, Inc. (NEO)vs › | $429.88M | N/A | 3.29% | 4.78% | 5.98% |
| Myriad Genetics, Inc. (MYGN)vs › | $410.18M | N/A | 0.27% | 3.53% | 4.14% |
| Editas Medicine, Inc. (EDIT)vs › | $430.46M | N/A | 2.75% | 2.75% | 2.75% |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
